Kentucky Farm Bureau Mutual Insurance Co bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 10,000 shares of the conglomerate's stock, valued at approximately $1,905,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Danaher in the second quarter valued at approximately $10,492,520,000. Norges Bank bought a new stake in Danaher during the fourth quarter worth approximately $2,177,106,000. Generation Investment Management LLP acquired a new stake in Danaher in the second quarter worth approximately $1,287,949,000. Flossbach Von Storch SE acquired a new stake in Danaher in the second quarter worth approximately $747,260,000. Finally, Bank of New York Mellon Corp bought a new position in Danaher during the 2nd quarter valued at $712,875,000. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have recently issued reports on DHR shares. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 22nd. Wall Street Zen cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price target on the stock. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an "overweight" rating for the company in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $228.91.
Check Out Our Latest Research Report on Danaher
Danaher Trading Up 6.2%
Danaher stock opened at $211.92 on Thursday. The company has a 50 day moving average price of $194.30 and a 200 day moving average price of $192.44. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market capitalization of $148.98 billion, a price-to-earnings ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78.
Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company's revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 EPS. Research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
